linseed oil

Botanicalexperimental

Linseed oil, also known as flaxseed oil or flax oil, is a colorless to yellowish oil obtained from the dried, ripened seeds of the flax plant. The oil is obtained by pressing, sometimes followed by solvent extraction. — Wikipedia

Clinical trial activity

25 trials · 40 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
3
Phase 3
1
Phase 4
0

Earliest trial started Nov 1, 2001 (NCT00252486)

Timeline

2000s

  1. Jan 1, 2005

    Earliest Phase 2 Sponsor(trial)

2010s

  1. Jan 1, 2012

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • flax oil
  • flax oil
  • flax seed oil
  • flaxseed oil
  • flaxseed oil
  • linseed oil
  • linseed oil
  • linseed oil

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05068557N/ASep 24, 2021University of Guadalajara
NCT03558776N/AMar 13, 2018Friedrich Schiller University
NCT03141931N/AJul 1, 2017Government of Australia, Stiltec Pty Ltd, University of New South Wales
NCT02201758Phase 2Jan 1, 2017University of Bath, University of Saskatchewan
NCT02317588Phase 1Dec 1, 2014Canadian Institutes of Health Research (CIHR), Manitoba Health Research Council, University of Manitoba
NCT01912170N/AAug 1, 2013National Natural Science Foundation of China, Zhejiang University
NCT01857167N/AJun 1, 2013National Natural Science Foundation of China, Zhejiang University
NCT01619020N/AOct 1, 2012National Cancer Institute (NCI), Texas A&M University, University of Washington
NCT01593969Phase 2May 1, 2012University of Oxford, Wellcome Trust
NCT02103556N/AApr 1, 2012Fundação de Amparo à Pesquisa do Estado de São Paulo, University of Sao Paulo
NCT01317290Early Phase 1 (Phase 1)Feb 1, 2012Friedrich Schiller University, German Research Foundation
NCT01517685N/AJan 1, 2012Hallelujah Acres
NCT01604681N/AJan 1, 2011Conselho Nacional de Desenvolvimento Científico e Tecnológico, Federal University of Rio de Janeiro, Rio de Janeiro State University
NCT01391624Phase 2/Phase 3 (Phase 3)Aug 1, 2010Associação Fundo de Incentivo à Pesquisa, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado de São Paulo, University of Sao Paulo
NCT01788917N/ASep 1, 2009Friedrich Schiller University
NCT00955227N/AJul 1, 2009Canadian Institutes of Health Research (CIHR), University of Manitoba
NCT01634776N/AFeb 1, 2009University of North Carolina at Chapel Hill
NCT00967733N/AFeb 1, 2009Harvard University
NCT00726271N/AJun 1, 2008State University of New York, State University of New York, Syracuse
NCT00612560N/ANov 1, 2007AstraZeneca, National Center for Complementary and Integrative Health (NCCIH), State University of New York, Buffalo
Showing 20 of 25 trials
Page 1 / 2

Organizations

Research & Development (40)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Friedrich Schiller UniversityAcademic/Hospital3322009
National Center for Complementary and Integrative Health (NCCIH)Government3012007
Canadian Institutes of Health Research (CIHR)Academic/Hospital2022009
Conselho Nacional de Desenvolvimento Científico e TecnológicoGovernment2022010
Fundação de Amparo à Pesquisa do Estado de São PauloAcademic/Hospital2022010
National Natural Science Foundation of ChinaGovernment2012013
University of ManitobaAcademic/Hospital2222009
University of Sao PauloAcademic/Hospital2222010
Zhejiang UniversityAcademic/Hospital2212013
Associação Fundo de Incentivo à PesquisaGovernment1012010
AstraZenecaFor profit1012007
Federal University of Rio de JaneiroAcademic/Hospital1112011
German Research FoundationAcademic/Hospital1012012
Government of AustraliaGovernment1012017
Hallelujah AcresAcademic/Hospital1112012
Harvard UniversityAcademic/Hospital1112009
Manitoba Health Research CouncilAcademic/Hospital1012014
Mayo ClinicAcademic/Hospital1112005
National Cancer Institute (NCI)Government1012012
National Institutes of Health (NIH)Government1012007
40 organizations
Page 1 / 2